What is the address of RITANDY THERAPY?

The registered office of RITANDY THERAPY is located at Waterstraat 36, 1570 Pajottegem.

Is RITANDY THERAPY still active?

Yes. According to the CBE (30 October 2026) RITANDY THERAPY is active, legal situation “Normale toestand”, started on 4 September 2000.

Is RITANDY THERAPY registered on Peppol?

No, RITANDY THERAPY is currently not registered on the Peppol network.

What is the enterprise number of RITANDY THERAPY?

The enterprise number of RITANDY THERAPY is BE0472684859.

When was RITANDY THERAPY founded?

RITANDY THERAPY was founded on 4 September 2000.

Who are the directors of RITANDY THERAPY?

According to the 2025 annual accounts, the directors of RITANDY THERAPY are: André VETSUYPENS.

Is RITANDY THERAPY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 September 2000; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did RITANDY THERAPY make in 2025?

RITANDY THERAPY posted a profit after taxes of € 14,207 in financial year 2025.

What is the revenue of RITANDY THERAPY?

As a small company, RITANDY THERAPY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 18,795.

RITANDY THERAPY (Private Limited) - Pajottegem

Dossier RITANDY THERAPY, printed on 30 October 2026 from databakkes.be/en/0472684859/ritandy-therapy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

RITANDY THERAPY from Pajottegem, company number BE0472684859, closed financial year 2025 with a result of € 14,207 after tax. For that financial year RITANDY THERAPY recorded a gross margin of € 18,795 and equity of € 106,715. Compared with financial year 2024, the result moved from € -1,747 to € 14,207. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 28, 2026.

What it is worth Growing

€ 106,715

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 14,207

▲ still € 1,747 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 26,597

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 88,123.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

€ 13,048

▼ 55% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 18,084

▲ € 16,563 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 5,388

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 14,506 Gross margin 2022: € 14,506 First fiscal year in the series	€ 9,222 Gross margin 2023: € 9,222 ▼ 36% vs 2022 (€ 14,506) Unfavourable step	€ 6,531 Gross margin 2024: € 6,531 ▼ 29% vs 2023 (€ 9,222) Unfavourable step	€ 18,795 Gross margin 2025: € 18,795 ▲ 188% vs 2024 (€ 6,531) Favourable step	▲ 188%
Profit after taxes	€ 1,737 Profit after taxes 2022: € 1,737 First fiscal year in the series	€ -1,304 Profit after taxes 2023: € -1,304 ▼ € 3,041 vs 2022 (€ 1,737) Unfavourable step	€ -1,747 Profit after taxes 2024: € -1,747 ▼ € 443 vs 2023 (€ -1,304) Unfavourable step	€ 14,207 Profit after taxes 2025: € 14,207 ▲ € 15,953 vs 2024 (€ -1,747) Favourable step	▲ € 15,953
Equity	€ 95,559 Equity 2022: € 95,559 First fiscal year in the series	€ 94,255 Equity 2023: € 94,255 ▼ 1% vs 2022 (€ 95,559) Unfavourable step	€ 92,508 Equity 2024: € 92,508 ▼ 2% vs 2023 (€ 94,255) Unfavourable step	€ 106,715 Equity 2025: € 106,715 ▲ 15% vs 2024 (€ 92,508) Favourable step	▲ 15%
Total debts	€ 44,703 Total debts 2022: € 44,703 First fiscal year in the series	€ 40,268 Total debts 2023: € 40,268 ▼ 10% vs 2022 (€ 44,703) Favourable step	€ 30,823 Total debts 2024: € 30,823 ▼ 23% vs 2023 (€ 40,268) Favourable step	€ 36,521 Total debts 2025: € 36,521 ▲ 18% vs 2024 (€ 30,823) Unfavourable step	▲ 18%
Cash	€ 21 Cash 2022: € 21 First fiscal year in the series	€ 8 Cash 2023: € 8 ▼ 62% vs 2022 (€ 21) Unfavourable step	-	€ 26,597 Cash 2025: € 26,597 First fiscal year in the series
Retained profit	€ 76,967 Retained profit 2022: € 76,967 First fiscal year in the series	€ 75,663 Retained profit 2023: € 75,663 ▼ 2% vs 2022 (€ 76,967) Unfavourable step	€ 73,916 Retained profit 2024: € 73,916 ▼ 2% vs 2023 (€ 75,663) Unfavourable step	€ 88,123 Retained profit 2025: € 88,123 ▲ 19% vs 2024 (€ 73,916) Favourable step	▲ 19%
Bank debt	€ 40,864 Bank debt 2022: € 40,864 First fiscal year in the series	€ 35,909 Bank debt 2023: € 35,909 ▼ 12% vs 2022 (€ 40,864) Favourable step	€ 29,302 Bank debt 2024: € 29,302 ▼ 18% vs 2023 (€ 35,909) Favourable step	€ 13,048 Bank debt 2025: € 13,048 ▼ 55% vs 2024 (€ 29,302) Favourable step	▼ 55%
Balance sheet total	€ 140,263 Balance sheet total 2022: € 140,263 First fiscal year in the series	€ 134,523 Balance sheet total 2023: € 134,523 ▼ 4% vs 2022 (€ 140,263) Unchanged	€ 123,332 Balance sheet total 2024: € 123,332 ▼ 8% vs 2023 (€ 134,523) Unchanged	€ 143,236 Balance sheet total 2025: € 143,236 ▲ 16% vs 2024 (€ 123,332) Unchanged	▲ 16%

Key figures of RITANDY THERAPY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to RITANDY THERAPY?

What happened at RITANDY THERAPY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 28, 2026 New annual accounts for financial year 2025: profit of € 14,207. filed late Source: NBB ↗
2000 André VETSUYPENS became a director. NBB
Sep 4, 2000 Start of the company according to the CBE. KBO
Aug 24, 2000 New establishment in Pajottegem. KBO

In short

From € 1,737 profit in 2022 to € 14,207 profit in 2025.

Paid € 5,850 in corporate taxes since 2022.

Best year ever: 2025, with € 14,207 profit.

Original PDFs at the National Bank ↗

Management

André VETSUYPENS

RITANDY THERAPY

Behind RITANDY THERAPY is André VETSUYPENS.

Directors

According to the 2025 annual accounts

André VETSUYPENS

Administrator-manager

since 2000

Establishments

Establishment units

Physical locations of this company

Registered office

Waterstraat 36

1570 Pajottegem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0472.684.859
VAT number: BE 0472.684.859
Registered office: Waterstraat 36, 1570 Pajottegem
Names & denominations: RITANDY THERAPY
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 September 2000
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗